Business Description
VolitionRX Ltd
NAICS : 325413
SIC : 2836
ISIN : US9286611077
Description
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.92 | |||||
| Equity-to-Asset | -1.7 | |||||
| Debt-to-Equity | -0.27 | |||||
| Debt-to-EBITDA | -0.21 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -33.61 | |||||
| Beneish M-Score | -0.94 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -4 | |||||
| 3-Year EPS without NRI Growth Rate | -3.3 | |||||
| 3-Year FCF Growth Rate | 12.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 55.91 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.84 | |||||
| 9-Day RSI | 53.04 | |||||
| 14-Day RSI | 51.04 | |||||
| 6-1 Month Momentum % | 17.2 | |||||
| 12-1 Month Momentum % | 18.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.22 | |||||
| Quick Ratio | 0.22 | |||||
| Cash Ratio | 0.18 | |||||
| Days Sales Outstanding | 50.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19 | |||||
| Shareholder Yield % | -17.44 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -2323.16 | |||||
| Net Margin % | -2321.13 | |||||
| FCF Margin % | -1142.04 | |||||
| ROA % | -163.82 | |||||
| ROIC % | -107.71 | |||||
| ROC (Joel Greenblatt) % | -523.5 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 40.87 | |||||
| EV-to-EBIT | -1.95 | |||||
| EV-to-EBITDA | -2.04 | |||||
| EV-to-Revenue | 45.2 | |||||
| EV-to-Forward-Revenue | 34.79 | |||||
| EV-to-FCF | -3.96 | |||||
| Earnings Yield (Greenblatt) % | -51.28 | |||||
| FCF Yield % | -24.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:VNRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
VolitionRX Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.287 | ||
| EPS (TTM) ($) | -0.36 | ||
| Beta | 1.23 | ||
| Volatility % | 74.63 | ||
| 14-Day RSI | 51.04 | ||
| 14-Day ATR ($) | 0.078848 | ||
| 20-Day SMA ($) | 0.621005 | ||
| 12-1 Month Momentum % | 18.42 | ||
| 52-Week Range ($) | 0.4301 - 1.23 | ||
| Shares Outstanding (Mil) | 95.97 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
VolitionRX Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
VolitionRX Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
VolitionRX Ltd Frequently Asked Questions
What is VolitionRX Ltd(VNRX)'s stock price today?
The current price of VNRX is $0.65. The 52 week high of VNRX is $1.23 and 52 week low is $0.43.
When is next earnings date of VolitionRX Ltd(VNRX)?
The next earnings date of VolitionRX Ltd(VNRX) is 2025-03-26 Est..
Does VolitionRX Ltd(VNRX) pay dividends? If so, how much?
VolitionRX Ltd(VNRX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers